21 Einträge gefunden

1. Parthenogenetic stem cells for tissue-engineered heart repair

   1. Didié, Michael
   2. Christalla, Peter
   3. Rubart, Michael
   4. Muppala, Vijayakumar
   5. Döker, Stephan
   6. Unsöld, Bernhard
   7. El-Armouche, Ali

   2013 - Forschungsinformationssystem des UKE
2. Impact of the β1-adrenoceptor Arg389Gly polymorphism on heart-rate responses to bisoprolol and carvedilol in heart-failure patients.

   1. Rau, Thomas
   2. Düngen, H-D
   3. Edelmann, F
   4. Waagstein, F
   5. Lainščak, M
   6. Dimković, S
   7. Apostolović, S

   2012 - Forschungsinformationssystem des UKE
3. Progesterone receptor variants associated with the PROGINS haplotype exhibit functional properties similar to those of wild-type progesterone receptor.

   1. Stenzig, Justus
   2. Schweikert, Andreas
   3. Piasecki, Angelika
   4. Höppner, Grit
   5. Eschenhagen, Thomas
   6. Rau, Thomas

   2012 - Forschungsinformationssystem des UKE
4. Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology.

   1. Schaaf, Sebastian
   2. Shibamiya, Aya
   3. Mewe, Marco
   4. Eder, Alexandra
   5. Stöhr, Andrea
   6. Hirt, Marc
   7. Rau, Thomas

   2011 - Forschungsinformationssystem des UKE - frei zugänglich
5. Pharmacogenetic characteristics of patients with complicated phenprocoumon dosing.

   1. Werner, D
   2. Werner, U
   3. Wuerfel, A
   4. Grosch, A
   5. Lestin, H
   6. Eschenhagen, Thomas
   7. Rau, Thomas

   2009 - Forschungsinformationssystem des UKE
6. Impact of the CYP2D6 genotype on the clinical effects of metoprolol: a prospective longitudinal study.

   1. Rau, Thomas
   2. Wuttke, H
   3. Michels, L M
   4. Werner, U
   5. Bergmann, K
   6. Kreft, M
   7. Fromm, M F

   2009 - Forschungsinformationssystem des UKE
7. [25 years of progress in pharmacology: many innovations--are you up to date?]

   1. Eschenhagen, Thomas
   2. Rau, Thomas

   2008 - Forschungsinformationssystem des UKE
8. The 2988G>A polymorphism affects splicing of a CYP2D6 minigene.

   1. Rau, Thomas
   2. Diepenbruck, Silke
   3. Diepenbruck, Ines
   4. Eschenhagen, Thomas

   2006 - Forschungsinformationssystem des UKE
9. High-dose methotrexate in pediatric acute lymphoblastic leukemia: impact of ABCC2 polymorphisms on plasma concentrations.

   1. Rau, Thomas
   2. Erney, Birgit
   3. Göres, Ralf
   4. Eschenhagen, Thomas
   5. Beck, Jörn
   6. Langer, Thorsten

   2006 - Forschungsinformationssystem des UKE
10. Atorvastatin desensitizes beta-adrenergic signaling in cardiac myocytes via reduced isoprenylation of G-protein gamma-subunits.

    1. Mühlhäuser, Ulrike
    2. Zolk, Oliver
    3. Rau, Thomas
    4. Münzel, Felix
    5. Wieland, Thomas
    6. Eschenhagen, Thomas

    2006 - Forschungsinformationssystem des UKE
11. Key role of myosin light chain (MLC) kinase-mediated MLC2a phosphorylation in the alpha 1-adrenergic positive inotropic effect in human atrium.

    1. Grimm, Michael
    2. Haas, Pascal
    3. Willipinski-Stapelfeldt, Birthe
    4. Zimmermann, Wolfram-Hubertus
    5. Rau, Thomas
    6. Pantel, Klaus
    7. Weyand, Michael

    2005 - Forschungsinformationssystem des UKE
12. Human homozygous R403W mutant cardiac myosin presents disproportionate enhancement of mechanical and enzymatic properties.

    1. Keller, Dagmar I
    2. Coirault, Catherine
    3. Rau, Thomas
    4. Cheav, Theary
    5. Weyand, Michael
    6. Amann, Kerstin
    7. Lecarpentier, Yves

    2004 - Forschungsinformationssystem des UKE
13. [Beta blockers in cardiac insufficiency. When, how much and which substance]

    1. Wuttke, Henrike
    2. Rau, Thomas
    3. Eschenhagen, Thomas

    2004 - Forschungsinformationssystem des UKE
14. CYP2D6 genotype: impact on adverse effects and nonresponse during treatment with antidepressants-a pilot study.

    1. Rau, Thomas
    2. Wohlleben, Gerlinde
    3. Wuttke, Henrike
    4. Thuerauf, Norbert
    5. Lunkenheimer, Jens
    6. Lanczik, Mario
    7. Eschenhagen, Thomas

    2004 - Forschungsinformationssystem des UKE
15. Formation of molecular complexes by N-methyl-D-aspartate receptor subunit NR2B and ryanodine receptor 2 in neonatal rat myocard.

    1. Seeber, Silke
    2. Humeny, Andreas
    3. Herkert, Matthias
    4. Rau, Thomas
    5. Eschenhagen, Thomas
    6. Becker, Cord-Michael

    2004 - Forschungsinformationssystem des UKE
16. Evidence for protein phosphatase inhibitor-1 playing an amplifier role in beta-adrenergic signaling in cardiac myocytes.

    1. El-Armouche, Ali
    2. Rau, Thomas
    3. Zolk, Oliver
    4. Ditz, Diana
    5. Pamminger, Torsten
    6. Zimmermann, Wolfram-H
    7. Jäckel, Elmar

    2003 - Forschungsinformationssystem des UKE
17. Overexpression of wild-type Galpha(i)-2 suppresses beta-adrenergic signaling in cardiac myocytes.

    1. Rau, Thomas
    2. Nose, Monika
    3. Remmers, Ute
    4. Weil, Joachim
    5. Weissmüller, Astrid
    6. Davia, Kerry
    7. Harding, Sian

    2003 - Forschungsinformationssystem des UKE
18. Inhibitory G-proteins and their role in desensitization of the adenylyl cyclase pathway in heart failure.

    1. El-Armouche, Ali
    2. Zolk, Oliver
    3. Rau, Thomas
    4. Eschenhagen, Thomas

    2003 - Forschungsinformationssystem des UKE
19. Increased frequency of cytochrome P450 2D6 poor metabolizers among patients with metoprolol-associated adverse effects.

    1. Wuttke, Henrike
    2. Rau, Thomas
    3. Roland, Heide
    4. Bergmann, Klaus
    5. Böhm, Michael
    6. Weil, Joachim
    7. Werner, Dierk

    2002 - Forschungsinformationssystem des UKE
20. Physiological antagonism between ventricular beta 1-adrenoceptors and alpha 1-adrenoceptors but no evidence for beta 2- and beta 3-adrenoceptor function in murine heart.

    1. Heubach, Jürgen F
    2. Rau, Thomas
    3. Eschenhagen, Thomas
    4. Ravens, Ursula
    5. Kaumann, Alberto J

    2002 - Forschungsinformationssystem des UKE